GlobeNewswire by notified

Terranet AB – Year end report 2023


Significant events during the fourth quarter

  • The company was awarded a grant from Skyltfonden (an initiative of the Swedish Transport Administration) for the development of new testing methods in collaboration with AstaZero (RISE).
  • Dan Wahrenberg took over as the new CFO.
  • The company and Nihat Kücük reached an agreement on the termination of Nihat’s employment as CTO.
  • Pierre Ekwall took over as the new CTO.
  • The subscription of warrants in series T06 was carried out, with a subscription rate of 63% (the company raised approximately MSEK 6.3).

Significant events after the close of the period

  • The company’s board decided to crry out a directed issue of units amounting to MSEK 10 before issue costs and an issue of TO8 to the Company for transfer free of charge to the Company's shareholders.
  • The company held an extraordinary general meeting on January 31 where it was resolved to elect Mats Fägerhag as a new ordinary board member and further resolved on a directed issue of units to Maida Vale Capital AB of SEK 2.25 million.
  • CEO Magnus Andersson and CTO Pierre Ekwall participated in CES in Las Vegas.

Q4, 1 October – 31 December 2023

  • Revenue amounted to TSEK 205 (310).
  • Operating profit/loss amounted to TSEK -9,219 (-7,431).
  • Diluted and undiluted earnings per share amounted to SEK -0.02 (-0.03).

Full year, 1 January–31 December 2023

  • Revenue amounted to TSEK 834 (748).
  • Operating profit/loss amounted to TSEK -35,926 (-29,371).
  • Diluted and undiluted earnings per share amounted to SEK -0.08 (-0.10).
  • Cash and cash equivalents for the Group amounted to TSEK 29,006 (26,715) at the close of the period.
  • The Board proposes that no dividend be paid for the 2023 financial year.

Comments from the CEO

Today's safety solutions in the automotive industry do not work well enough, and what we at Terranet offer will help save more lives and enable new mobility innovations for a safer and more efficient traffic environment.

We have seen an exciting close to an eventful 2023, with a fourth quarter marked by a number of significant steps forward. After years of hard work, BlincVision, our anti-collision project, is beginning to show its full potential as a comprehensive solution. We are seeing increased interest from potential customers and partners and can confidently state that the sector is looking for a product with the kind of speed and precision that BlincVision can offer.

Product development is progressing according to plan, and we are following our previously communicated product development plan; in 2024, we will demonstrate our prototype in a laboratory environment in the first quarter, and then in the second quarter we will demonstrate our prototype on vehicles in a test environment outdoors. The initial testing of a prototype showed promising results, offering good opportunities for product development before presentation to external parties. Our goal is to create formal partnerships with Tier 1 suppliers and automakers in 2024. We are moving closer and closer to a finished product that will be attractive on the market.

Continuous dialogues with Tier 1 suppliers and vehicle manufacturers have confirmed that there continues to be a great deal of interest in what we do across a number of different sectors, both in the area of driver assistance and autonomous vehicles. We continue to increase our commercial capability and have just elected Mats Fägerhag to the board. As a operational advisor, Mats brings many years of experience in the automotive industry and vast knowledge in the area of product development and commercialization. We are also engaged in an ongoing recruitment effort within business development.

At this year's CES, one of the world’s premier trade shows for the automotive industry and tech sector, advanced driver assistance systems (ADAS) continued to be one of the hottest topics. Car manufacturers and suppliers acknowledge that existing anti-collision solutions are in need of improvement.

Despite the fact that many car models are currently equipped with advanced driver assistance systems, a high number of accidents still occur. And the continued high rate of accidents is especially concerning in cities, where accidents occur between cars and vulnerable road users. Solving this problem will require faster and more precise sensor technology. “Terranet offers technology that will help solve these problems, save lives and enable new mobility innovations for a safer and more efficient traffic environment”. In light of the above, the collaboration that we initiated in the autumn of last year with AstaZero's test track and the interest from EuroNCAP are quite relevant.

We are now entering an incredibly intense period where years of development shall materialize. These are without a doubt the most exciting months we have ahead of us since Terranet was founded. We plan to update you shareholders in the coming months as we step by step in 2024 work towards our goal – to sign agreements and enter into partnerships with Tier 1 suppliers and leading car manufacturers.

We look forward to keeping you updated on what is sure to be a very eventful 2024!

Magnus Andersson
Lund, 22 February 2024

This information is such that Terranet AB is required to make public in accordance with the EU’s Market Abuse Regulation (MAR). The information was made public by the Company’s contact person below on 22 February 2024, at 08.00 CET.

For more information, please contact
Magnus Andersson CEO

About Terranet AB (publ)

Terranet is on a mission to save lives in urban traffic. 

We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) that protect vulnerable road users.

With a unique and patented vision technology, Terranet’s anti-collision system BlincVision scans and detects road objects multiple times faster and with higher accuracy than any other ADAS technology available today.

Terranet is based in Lund, Sweden, and in the heart of the European automotive industry in Stuttgart, Germany. The company is listed on Nasdaq First North Premier Growth Market since 2017(Nasdaq: TERRNT-B). 

Follow our journey at

Certified Adviser to Terranet is Mangold Fondkommission AB, 08-503 015 50,


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

AKVA group ASA: Status buyback of own shares15.4.2024 18:00:24 CEST | Press release

As announced on 22 March 2024 AKVA group ASA ("AKVA group" or the "Company") has initiated repurchase of up to 200,000 of the company's own shares to be used in its share programme for employees. From 5 April through 15 April the company bought 15 746 shares at an weighted average price of NOK 69,7155. See the attached document for detailed information about the transactions made. The company has bought a total of 29 718 shares at an weighted average price of NOK 69,1760 since 22 March. After these transactions, the company owns 260 381 treasury shares. This information is made public by the Company pursuant to the EU Market Abuse Regulation article 5, as supplemented by Commission Delegated Regulation (EU) 2016/1052 and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. Dated: 15 April 2024 AKVA group ASA Web: CONTACTS: Knut Nesse Chief Executive OfficerPhone:+47 51 77 85 00Mobile:+47 91 37 62 20E-mail:knesse@akva

Solvay publishes 2023 quarterly information following restatement and new segmentation reporting15.4.2024 18:00:00 CEST | Press release

Press release published on April 15, 2024, at 6:00 p.m. CEST Solvay publishes unaudited underlying Sales and EBITDA for the four quarters of 2023, before and after the restatements announced in the March 13th 2024 press release: Summary table with Underlying EBITDA and Net Sales impacts: in € millionimpactUnderlying EBITDAUnderlying net sales 2023 underlying figures, as published 1,246 4,880 phase-out thermal insulation business scope -54 -107 phase-out third party energy supply activities scope -41 N/A Dis-synergies, net of the “Transition Services Agreement” mark-up scope -12 N/A Zhenjiang scope -8 -25 Peroxidos do Brasil APM +23 +163 2023 underlying figures, new base 1,154 4,911 This restated consolidated financial information provides for underlying Sales and EBITDA detailed information for the four quarters of 2023 for the new reporting segments: Basic Chemicals host chemical intermediate businesses focused on mature and resilient markets. Solvay is a world leader in soda ash, bic

Festi hf: Festi acquisition of all shares in Lyfja hf. – Conciliation talks begin with the Icelandic Competition Authority.15.4.2024 17:51:30 CEST | Press release

The Icelandic Competition Authority has agreed to Festi’s request to start conciliation talks on possible remedies associated with Festi’s acquisition of all shares in Lyfja hf. The conciliation talks are expected to start this week. Reference is made to Festi’s announcement, published on the 18th of March 2024, regarding the preliminary conclusions in the Icelandic Competition Authority’s investigation into the competitive effects of Festi’s purchase on the entire share capital of Lyfja hf. It is stated therein that the merger will, based on the current state of the investigation, require intervention by the Icelandic Competition Authority. In Festi’s announcement, published on the 26th of March 2024, it was reported that the company had submitted a response to the Icelandic Competition Authority‘s preliminary conclusions where Festi‘s arguments and proposals for remedies were presented. The response formally requested a conciliation talks with the Icelandic Competition Authority on p

Rapala VMC Corporation: Board member Jorma Kasslin has passed away15.4.2024 17:30:00 CEST | Press release

Rapala VMC Corporation, Changes board/management/auditors, April 15, 2024, at 06:30 p.m. EET Long-time Board member of Rapala VMC Corporation, Jorma Kasslin, has passed away. He died suddenly after a brief illness on April 14, 2024. Kasslin was 70 years old and had been a member of Rapala VMC's Board of Directors since 1998, serving as Chairman from 2016 to 2018 and as President and CEO from 1998 to 2016. The Board of Directors, management, and staff of Rapala VMC Corporation extend their deepest condolences to the family and loved ones of Jorma Kasslin. During Jorma Kasslin's tenure as CEO, Rapala VMC expanded into an international enterprise, becoming a global market leader in several segments of the sports fishing business. He was a leader who placed great importance on the well-being of the staff. Colleagues from around the world will miss Jorma dearly. "Jorma was my leader for many years, starting from 1998. He was an encouraging director who provided everyone with a common direct

Publication Annual Report – Annual Shareholders' Meeting15.4.2024 17:16:00 CEST | Press release

Publication Annual Report – Annual Shareholders' Meeting Leuven, BELGIUM – April 15, 2024 – 05:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial year 2023. The annual report for the year ending December 31, 2023 is available in the “Investors” section of the Company’s website, and can also be downloaded as a PDF. On this day as well, the Company has convened its Annual Shareholders' Meeting. The relevant documents pertaining to this Meeting have been published in the section “Shareholder Meetings” here. About Oxurion Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at Please contact for additional information: Oxurion NV Pascal Ghoson Chief Executive Officer Backstage Comm

HiddenA line styled icon from Orion Icon Library.Eye